Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The CD52 antigen and development of the CAMPATH antibodies.

× No keyword cloud information.

42 in total

Review 1. Neuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications.

Authors: Stefan Bittner; Heinz Wiendl
Journal: Neurotherapeutics Date: 2016-01 Impact factor: 7.620

Review 2. Cutaneous T-cell lymphomas: a review of new discoveries and treatments.

Authors: Tara Bloom; Timothy M Kuzel; Christiane Querfeld; Joan Guitart; Steven T Rosen
Journal: Curr Treat Options Oncol Date: 2012-03

Review 3. Anti-cancer immune response mechanisms in neoadjuvant and targeted therapy.

Authors: Carsten Denkert; Silvia Darb-Esfahani; Sibylle Loibl; Ioannis Anagnostopoulos; Korinna Jöhrens
Journal: Semin Immunopathol Date: 2011-04-17 Impact factor: 9.623

Review 4. Lymphodepletional strategies in transplantation.

Authors: Eugenia Page; Jean Kwun; Byoungchol Oh; Stuart Knechtle
Journal: Cold Spring Harb Perspect Med Date: 2013-07-01 Impact factor: 6.915

5. Phase 1/2 study of alemtuzumab with dose-adjusted EPOCH in untreated aggressive T and NK cell lymphomas.

Authors: Joseph Roswarski; Mark Roschewski; Christopher Melani; Stefania Pittaluga; Andrea Lucas; Seth M Steinberg; Elaine S Jaffe; Thomas A Waldmann; Wyndham H Wilson
Journal: Leuk Lymphoma Date: 2019-01-10

Review 6. Novel and emerging targeted-based cancer therapy agents and methods.

Authors: Mohammad Hojjat-Farsangi
Journal: Tumour Biol Date: 2015-02-09

7. Alemtuzumab-induced remission of multiple sclerosis-associated uveitis.

Authors: Mark D Willis; Trevor P Pickersgill; Neil P Robertson; Richard W J Lee; Andrew D Dick; Ester Carreño
Journal: Int Ophthalmol Date: 2016-10-11 Impact factor: 2.031

8. Alemtuzumab as compared to alternative contemporary induction regimens.

Authors: John C LaMattina; Joshua D Mezrich; R Michael Hofmann; David P Foley; Anthony M D'Alessandro; Hans W Sollinger; John D Pirsch
Journal: Transpl Int Date: 2012-03-06 Impact factor: 3.782

Review 9. The immunological function of CD52 and its targeting in organ transplantation.

Authors: Yang Zhao; Huiting Su; Xiaofei Shen; Junfeng Du; Xiaodong Zhang; Yong Zhao
Journal: Inflamm Res Date: 2017-03-10 Impact factor: 4.575

10. Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemia.

Authors: Andrew Mone; Shannon Puhalla; Susan Whitman; Robert A Baiocchi; Julio Cruz; Tamara Vukosavljevic; Amy Banks; Charles F Eisenbeis; John C Byrd; Michael A Caligiuri; Pierluigi Porcu
Journal: Blood Date: 2005-08-02 Impact factor: 22.113